CClinicalTrials.gg
CompletedNCT02017821Updated Aug 13, 2014

The Effect of Aerobic Endurance Training in Patients With Drug Addiction

An interventional study of high intensity aerobic training in Substance-Related Disorders, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2014-08-13.

Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Physical health does not have a high priority in today's treatment of patients with substance use disorder (SUD) patients have a poor physical health not only due to injuries related to the substance abuse, but also because of the lifestyle that addiction causes. There are today few studies that provide information about SUD patients' physical health. One of the project's aims is to document the physical health of SUD patients in treatment, using objective measures. After completion of various physical tests, an 8 week period of high intensity aerobic training intervention will follow. It will be investigated if the SUD patients are able to engage and participate throughout the whole training intervention, to what degree the participants improve their physical health and the effect of physical health improvement on substance abuse treatment.

02

Conditions studied

  • Substance-Related Disorders

Keywords

  • Exercise
  • Oxygen Consumption
  • mental health
03

In context

Substance-Related Disorders

2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.

This study's enrollment of 24 is below the median of 108 across 1,727 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • substance use disorder diagnosed ICD10
  • written informed consent
  • "residential treatment"

Exclusion criteria

Exclusion Criteria:

  • not been using drugs the last six months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    training group

    high intensity aerobic training 3 weekly sessions for 8 weeks

    Behavioral: high intensity aerobic training

  • No intervention
    care as usual

Interventions

  • Behavioralhigh intensity aerobic training
06

What researchers measure

Primary outcomes

  1. change in maximal oxygen consumption (VO2 max)

    Directly measurement of maximal oxygen consumption. Measurement of work efficiency and lactate measurements. Insomnia Severity Index and Hospital Anxiety and Depression scale is used to measure mental health.

    Time frame: from baseline to 8 weeks

07

Study locations

1 site
  • Trondheims Klinikken, St Olavs Hospital
    Trondheim, Norway
08

References and documents

Publications

  • Flemmen G, Unhjem R, Wang E. High-intensity interval training in patients with substance use disorder. Biomed Res Int. 2014;2014:616935. doi: 10.1155/2014/616935. Epub 2014 Mar 2. PubMed 24724089 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02017821
Lead sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital
Responsible party
Sponsor
First posted
Dec 23, 2013
Start date
Aug 2012
Primary completion
Nov 2013
Completion
Jan 2014
Last update
Aug 13, 2014

Study contacts

Eivind Wang, phd
study director · Norwegian University of Science and Technology

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion